Navitor Pharmaceuticals launches with $23.5 million

June 19, 2014 11:13 AM

7 0

A new Cambridge biotech startup, Navitor Pharmaceuticals, launches today with a $23.5 million Series A funding and a researcher from the Whitehead Institute and MIT as its scientific founder.

Investors in the Series A financing include Polaris Partners, Atlas Venture, Johnson & Johnson Development Corporation, SR One, and The Longevity Fund.

Also read: Revised MLS stadium plan cuts St. Louis' share by $20M

Read more

To category page